Trending Now
The U.S. Government Has Awarded Novavax, Inc. (NASDAQ:NVAX) $1.6 Billion for...
Novavax, Inc. (NASDAQ:NVAX) is the latest beneficiary of the biggest from “Operation Warp Speed,” a White House program pursuing accelerated access to vaccines and...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Lyell Immunopharma Inc. (NASDAQ: LYEL) Announce FDA Approval of IND to...
Lyell Immunopharma Inc. (NASDAQ: LYEL) has announced that the US FDA has approved an investigational new drug application to commence the first phase clinical...
MAKE IT MODERN
LATEST REVIEWS
Baudax Bio (NASDAQ:BXRX) Offers Update On Commercial Launch Of ANJESO
Baudax Bio Inc. (NASDAQ:BXRX) has offered an update about the commercial launch of ANJESO and an update on its warrant exchange agreement.
The uptake of...
MAKE IT MODERN
PERFORMANCE TRAINING
Key Financial Highlights and Analysts’ Recommendations (COIN,FDX,FLNC,ALGN,CNC)
In a recent revelation by ADP, job creation in the U.S. witnessed a deceleration in August, falling short of expectations and hinting...
Invesco QQQ Trust (QQQ) in make or break mode
After finding some support at the major $280 level last week, the QQQ’s are trading in a very tight range this morning....
Evofem Biosciences Inc. (NASDAQ: EVFM) Posted Net Loss of $74.1 Million in Q3 As...
Evofem Biosciences Inc. (NASDAQ: EVFM) has announced its financial results for the quarter and nine months ended September 30, 2021.
Evofem reported net sales of...
Bright Health Group Inc (NYSE: BHG) Reports a 275% Revenue Increase in The...
Bright Health Group Inc (NYSE: BHG) recently released its financial and operational results for the second quarter of 2021. BHG is a diversified health...
The FDA Accepts Investigational New Drug (IND) Application for a Phase 2 Clinical Trial...
Capricor Therapeutics Inc. (NASDAQ:CAPR) is one of the companies fully involved in investigating exosome science. The company's exosome technology is reportedly active in several...
MAKE IT MODERN
